相似文献
1
Tay-Sachs disease: the search for the enzymatic defect.
Adv Genet. 2001;44:51-60. doi: 10.1016/s0065-2660(01)44070-3.
2
Discovery of beta-hexosaminidase A deficiency in Tay-Sachs disease.
Adv Genet. 2001;44:61-6. doi: 10.1016/s0065-2660(01)44071-5.
3
The GM2-gangliosidoses and the elucidation of the beta-hexosaminidase system.
Adv Genet. 2001;44:67-91. doi: 10.1016/s0065-2660(01)44072-7.
4
Discovery of the hexosaminidase isoenzymes.
Adv Genet. 2001;44:43-9. doi: 10.1016/s0065-2660(01)44069-7.
5
The beta-hexosaminidase story in Toronto: from enzyme structure to gene mutation.
Adv Genet. 2001;44:145-63. doi: 10.1016/s0065-2660(01)44077-6.
6
Cloning the beta-hexosaminidase genes.
Adv Genet. 2001;44:127-35. doi: 10.1016/s0065-2660(01)44075-2.
7
Recognition and delineation of beta-hexosaminidase alpha-chain variants: a historical and personal perspective.
Adv Genet. 2001;44:173-84. doi: 10.1016/s0065-2660(01)44079-x.
8
Subunit structure of the hexosaminidase isozymes.
Adv Genet. 2001;44:93-100. doi: 10.1016/s0065-2660(01)44073-9.
9
Molecular genetics of the beta-hexosaminidase isoenzymes: an introduction.
Adv Genet. 2001;44:101-26. doi: 10.1016/s0065-2660(01)44074-0.
10
Targeting the hexosaminidase genes: mouse models of the GM2 gangliosidoses.
Adv Genet. 2001;44:225-31. doi: 10.1016/s0065-2660(01)44082-x.
引用本文的文献
1
Emptying the stores: lysosomal diseases and therapeutic strategies.
Nat Rev Drug Discov. 2018 Feb;17(2):133-150. doi: 10.1038/nrd.2017.214. Epub 2017 Nov 17.
2
Sphingolipid lysosomal storage disorders.
Nature. 2014 Jun 5;510(7503):68-75. doi: 10.1038/nature13476.
Zotero 插件